The number of publications on mRNA vaccines not targeting COVID-19 has dramatically increased in the past two years.
Clinical Trials
The breakdown by clinical trial phase indicates that Phase 1 represents the largest percentage of studies being conducted on non-COVID-19 mRNA vaccines.
Top Diseases/Illnesses
The top diseases/therapeutic areas being mentioned in the published literature on mRNA vaccines not targeting covid-19 include:
Patents
151 patents have been registered globally on non-COVID-19 mRNA vaccines, with the US outpacing other geographies.
